Annual Biotechnology Congress July 23-24, 2018 Vancouver, British Columbia, Canada

CRISPR Technology

Genome editing and the utilization of CRISPR primarily based technologies are expected to revolutionize the assembly of the next generation of bio products. DCB12 can focus on the most recent developments within the use of CRISPR/Cas9 and alternative CRISPR primarily based technologies in reference to the development and production of biopharmaceuticals, bio chemicals, agricultural crops, and travel applications.

CRISPR is an abbreviation of Clustered Regularly Interspaced Short Palindromic Repeats. The name was minted at a time when the origin and use of the interspacing subsequences were not known. At that time the CRISPRs were described as segments of prokaryotic DNA containing short, repetitive base sequences. In a palindromic repeat, the sequence of nucleotides is the same in both directions. Each repetition is followed by short segments of spacer DNA from previous exposures to foreign DNA (e.g., a virus or plasmid). Small clusters of cas (CRISPR-associated system) genes are located next to CRISPR sequences.

• Genome engineering
• RNA editing
• Disease models
• Gene drive
• Biomedicine
• Gene function

Recommended Sessions

Related Journals

Are you interested in